Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 90 EP752 | DOI: 10.1530/endoabs.90.EP752

ECE2023 Eposter Presentations Pituitary and Neuroendocrinology (234 abstracts)

Response to quinagolide of a pituitary prolactin macroadenoma

Rahal Amel 1,2


1Medecines, Endocrinology, Algiers, Algeria; 2Hopital Bologhine Ibn Ziri, Endocrinology, Algiers, Algeria.


Introduction: The treatment of prolactin adenomas is medical based on the use of dopaminergic agonists but the presence of an underlying valvulopathy makes the treatment by cabergoline delicate.

Clinical case: We report the case of a 60 year old female patient, operated on for aortic valve disease, with moderate mitral leakage. On the occasion of a decrease in visual acuity; a prolactin macro adenoma is diagnosed In agreement with the cardiologist; we opt for a treatment with quinagolide at progressive dose leading to a decrease of prolactin with especially an improvement of the visual disorders

Conclusion: The presence of valvulopathy in patients with prolactin macroadenoma may hinder the practitioner in his therapeutic choice; although it is considered less effective than cabergoline, quinagolide has allowed the decompression of the visual pathways and remains an alternative in valvulopathic patients at risk.

Volume 90

25th European Congress of Endocrinology

Istanbul, Turkey
13 May 2023 - 16 May 2023

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.